You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

Citation Tools

Article menu
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Doi D, Konishi H, Yoneyama K, et al
0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer
International Journal of Gynecologic Cancer 2006;16:652.